BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7892186)

  • 21. A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane.
    Brightman AO; Wang J; Miu RK; Sun IL; Barr R; Crane FL; Morré DJ
    Biochim Biophys Acta; 1992 Mar; 1105(1):109-17. PubMed ID: 1567890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity.
    Kishi T; Morré DM; Morré DJ
    Biochim Biophys Acta; 1999 May; 1412(1):66-77. PubMed ID: 10354495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients.
    Morré DJ; Reust T
    J Bioenerg Biomembr; 1997 Jun; 29(3):281-9. PubMed ID: 9298713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
    Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
    Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients.
    Cho N; Chueh PJ; Kim C; Caldwell S; Morré DM; Morré DJ
    Cancer Immunol Immunother; 2002 May; 51(3):121-9. PubMed ID: 11941450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes.
    Kim C; Crane FL; Faulk WP; Morré DJ
    J Biol Chem; 2002 May; 277(19):16441-7. PubMed ID: 11875069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capsaicin-responsive NADH oxidase activities from urine of cancer patients.
    Yantiri F; Morré DJ; Yagiz K; Barogi S; Wang S; Chueh PJ; Cho N; Sedlak D; Morré DM
    Arch Biochem Biophys; 1998 Oct; 358(2):336-42. PubMed ID: 9784248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
    Chueh PJ; Wu LY; Morré DM; Morré DJ
    Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
    Morré DJ
    Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.
    Morré DJ; Wu LY; Morré DM
    Biochim Biophys Acta; 1998 Mar; 1369(2):185-92. PubMed ID: 9518604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone- and growth factor-stimulated NADH oxidase.
    Morré DJ
    J Bioenerg Biomembr; 1994 Aug; 26(4):421-33. PubMed ID: 7844117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential inhibition of the plasma membrane NADH oxidase (NOX) activity by diphenyleneiodonium chloride with NADPH as donor.
    Morré DJ
    Antioxid Redox Signal; 2002 Feb; 4(1):207-12. PubMed ID: 11970854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NADH oxidase of plasma membranes.
    Morré DJ; Brightman AO
    J Bioenerg Biomembr; 1991 Jun; 23(3):469-89. PubMed ID: 1864851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-plus ATP-dependent modulation of the NADH oxidase activity of porcine liver plasma membranes.
    Morré DJ; Navas P; Rodriguez-Aguilera JC; Morré DM; Villalba JM; de Cabo R; Lawrence J
    Biochim Biophys Acta; 1994 Dec; 1224(3):566-74. PubMed ID: 7803517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1).
    Lin MH; Lee YH; Cheng HL; Chen HY; Jhuang FH; Chueh PJ
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27367652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox modulation of the response of NADH oxidase activity of rat liver plasma membranes to cyclic AMP plus ATP.
    Morré DJ; Rodriguez-Aguilera JC; Navas P; Morre DM
    Mol Cell Biochem; 1997 Aug; 173(1-2):71-7. PubMed ID: 9278256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin.
    Wolvetang EJ; Larm JA; Moutsoulas P; Lawen A
    Cell Growth Differ; 1996 Oct; 7(10):1315-25. PubMed ID: 8891335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
    Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
    Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells.
    Alonso MM; Encío I; Martínez-Merino V; Gil M; Migliaccio M
    Br J Cancer; 2001 Nov; 85(9):1400-2. PubMed ID: 11720481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous two-phase partition and detergent precipitation of a drug-responsive NADH oxidase from the HeLa cell surface.
    Morré DM; Sweeting M; Morré DJ
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 711(1-2):173-84. PubMed ID: 9699986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.